STEM
Stem, Inc.
NYSE · Technology · Software - Infrastructure · US
$5.57
+1.09%Sep 1, 2026, 12:00 UTC
Regenerative Medical Technology Group, through its subsidiary Cellgenic, commenced commercial activity in Peru by establishing local commercial arrangements, including exclusive representation in permitted channels.
Source:Aug 13, 2026, 04:05 UTC
Stem reported its second-quarter results, highlighting continued profitability progress, higher software and edge-hardware revenue, and expanding utility-scale energy-management-system deployments internationally.
Source:Aug 12, 2026, 20:05 UTC
Stem, Inc. announced its financial results for the quarter ended June 30, 2026, reporting revenue of $33.7 million, down 12% from $38.4 million in the same quarter of the previous year.
Aug 12, 2026, 20:00 UTC
Solarmarkt Group, with EPC partner Pannonwatt, selected Stem's PowerTrack EMS for the hybridization of two operating utility-scale solar plants in Hungary.
Source:Jul 23, 2026, 11:02 UTC
Regenerative Medical Technologies Group, through its subsidiary Cellgenic, launched commercial operations in Argentina for biologic and regenerative medicine products.
Source:Jul 1, 2026, 12:05 UTC
Stem, Inc. won The smarter E AWARD 2026 for its PowerTrack Energy Management System in the Smart Integrated Energy category.
Source:Jun 17, 2026, 12:05 UTC
Stem Inc. launched AIONA, a dedicated AI services offering built for operational impact.
Source:Jun 3, 2026, 00:00 UTC
Stem, Inc. elected Ira Birns, Adam E. Daley, and Anil Tammineedi as Class II Directors effective June 3, 2026.